Mickey Boon Chai koh

Professor of Haematology

St George’s, University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Mickey Boon Chai Koh is a faculty member in the Department of Haematology at St George's University of London, United Kingdom. His research focuses on stem cell therapies, hematopoietic stem cell transplantation, and health equity in donation practices. He has contributed to various recent publications examining the global landscape of stem cell transplantation and recommendations for donor suitability in hematology.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Herbert Schwarz

National University of Singapore

SINGAPORE

View details

Christian Chabannon

Professor in Cell Biology

Aix-Marseille Université Faculté de Medecine

FRANCE

View details

Katharina Schallmoser

Professor for Transfusion Medicine, physician

Landeskrankenhaus Salzburg - Universitätsklinikum der Paracelsus Medizinischen Privatuniversität

AUSTRIA

View details

Andreas Buser

Prof. Dr. med., Director

SWITZERLAND

View details

Yating Li

National University of Singapore (NUS)

SINGAPORE

View details

Nina Worel

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mickey Boon Chai koh

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Stem cell therapies for diabetes

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies

Prioritising health equity alongside donation safety - Authors' reply.

Prioritising health equity alongside donation safety – Authors' reply

Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.

Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012.

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.

Collaborators (6)

Herbert Schwarz

Christian Chabannon

Katharina Schallmoser

Andreas Buser

Yating Li

Nina Worel

Make your next move.